Stay updated on Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.

Latest updates to the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page
- Check3 days agoChange DetectedA new version 1052 posted on 2026-10-01 updates the study's Contacts/Locations and Study Status. The prior version dated 2026-08-04 was removed.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page’s Revision line changes from v3.6.6 to v3.7.0, indicating a new release of the Study History page’s UI/structure without altering the underlying study data.SummaryDifference0.0%

- Check30 days agoChange DetectedA new Revision: v3.6.6 entry is added to the history, replacing the previous Revision: v3.6.5 entry.SummaryDifference0.0%

- Check52 days agoChange DetectedA new revision entry 'Revision: v3.6.5' was added to the study history. The previous 'Revision: v3.6.4' entry was removed, updating the history to the latest version.SummaryDifference0.0%

- Check59 days agoChange DetectedA new version 1051 was posted on 2026-08-01 introducing updated Study Status and Contacts/Locations sections, expanding the page history with current status and contact information. The prior version dated 2026-07-21 was removed.SummaryDifference0.0%

- Check74 days agoChange DetectedA new revision (v3.6.4) on 2026-07-21 adds References, Contacts/Locations, Oversight, and Study Status to the study record history, while the older revision (v3.6.3) from 2026-05-01 is removed.SummaryDifference0.0%

Stay in the know with updates to Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.